Health Care/Hospital
WellsCare to target Middle Eastern market for its homecare laser pain treatment device
SEOUL, South Korea, July 2, 2020 /PRNewswire/ -- WellsCare, a member company of the Born2Global Centre, will be expanding its presence in theMiddle East starting in July. WellsCare has been an active member company of theBorn2Global Centre since 2019.   WellsCare recently signe...
HeiQ Viroblock Certified as Cosmetic Grade and Bio-based Renewable
ZURICH, July 2, 2020 /PRNewswire/ -- Textile innovator HeiQ's antiviral textile
technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as
all its ingredients are cosmetic grade, bio-based, and recycled.
Affinity discovers potent SARS-CoV-2 antibodies
MELBOURNE, Australia, July 2, 2020 /PRNewswire/ -- Melbourne-based Affinity Biosciences Pty Ltd (Affinity), a privately held company focused on antibody discovery for cancer therapeutics, today announces the discovery of potent antibodies with therapeutic potential against COVID-19. In March, Af...
CF PharmTech, Inc. Closes a US $50M Series F Financing to Accelerate the Commercialization of its Inhalation Products.
SUZHOU, China, July 2, 2020 /PRNewswire/ -- CF PharmTech, Inc. ("CF PharmTech") announced today that it has raised US $50M in Series F financing following its US$90M Series E financing in January of 2020, in total, successfully completing an equity investment deal of nearly US$140M within six mon...
Antengene Corporation Appoints Former BMS Senior Leader of Biostatistics Zhinuan YU as Corporate Vice President of Biometrics and Regulatory Enabling Functions
SHANGHAI and PHILADELPHIA, July 1, 2020 /PRNewswire/ --Antengene Corporation today announced its appointment of Zhinuan Yu, Ph.D., as Corporate Vice President (CVP) of Biometrics and Regulatory Enabling Functions. Zhinuan will be responsible for providing statistical leadership and strategic r...
FibroGenesis Identifies Mechanism Responsible for Blocking COVID19-Like Lung Inflammation
Regenerative Medicine Company Advances Development of Fibroblast-Based Product as an "Off the Shelf"Cell-Treatment for Coronavirus Acute Respiratory Distress Syndrome (ARDS) HOUSTON, July 2, 2020 /PRNewswire/ -- FibroGenesis announced today identification of molecular mechanisms associated with ...
FibroGenesis Identifies Mechanism Responsible for Blocking COVID19-Like Lung Inflammation
Regenerative Medicine Company Advances Development of Fibroblast-Based Product as an "Off the Shelf"Cell-Treatment for Coronavirus Acute Respiratory Distress Syndrome (ARDS) HOUSTON, July 1, 2020 /PRNewswire/ -- FibroGenesis announced today identification of molecular mechanisms associated with ...
Polygiene is Overall Winner in Scandinavian Outdoor Group (SOG) Awards 2020
STOCKHOLM, July 1, 2020 /PRNewswire/ -- Each year a jury from the SOG reviews new products and technologies across several categories. This knowledgeable and competent jury picked Polygiene's ViralOff® as the best new technology of the year. ViralOff was also declared overall winner of 2020! "Al...
Transcenta Announces First Patient Dosed in Phase I Clinical Trial of Claudin18.2 Targeting Monoclonal Antibody TST001 in the US
SUZHOU, China, July 1, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced today that the first subject has been dosed successfull...
Hitachi and ThinkCyte announce collaboration to develop an AI-driven cell analysis and sorting system
TOKYO, July 1, 2020 /PRNewswire/ -- Hitachi, Ltd. (TSE: 6501, "Hitachi") and ThinkCyte, Inc. ("ThinkCyte") today announced that they have entered into a collaboration focused on developing an artificial intelligence (AI)-driven cell analysis and sorting system. Hitachi provides a broad range of s...
Coronavirus Breakthrough: New Study Highlights Senhwa Biosciences Silmitasertib as Potential Treatment for COVID-19
TAIPEI and SAN DIEGO, July 1, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on Next Generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that its drug Silmitasertib was again identified as o...
A RhoVac Article is Published in the June Edition of MedNous, a Publication of Evernow Publishing Ltd
STOCKHOLM, July 1, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") is published in the June edition of MedNous, through a written commentary by CEOAnders Månsson. In order to further attract the attention of potential partners and increase their interest in RhoVac's achievements as well as plans for t...
NCCN: What People with Cancer and their Caregivers Need to Know about CAR T-Cell Therapy
National Comprehensive Cancer Network's new NCCN Guidelines for Patients explain how to recognize and manage immunotherapy-related toxicities, help prepare patients for lengthy treatment duration PLYMOUTH MEETING, Pa., July 1, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN...
Yiling Pharmaceutical Lianhua Qingwen Capsule Extends Overseas Footprint in Southeast Asia
SHIJIAZHUANG, China, July 1, 2020 /PRNewswire/ -- Following Thailand, Singapore andIndonesia, Yiling Pharmaceutical (002603.SZ), a leader in the development of traditional Chinese medicines (TCM), obtained a Certificate of Registration issued by the Drug Department ofLaos' Ministry of Health whic...
Thermo Fisher Scientific Launches New MAS Omni Infectious Disease Quality Controls
FREMONT, California, July 1, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B &...
Anti-viral and Anti-Inflammatory Response: GoldenBiotech's Antroquinonol Receives FDA Approval on COVID-19 Phase 2 Trial in USA
TAIPEI, July 1, 2020 /PRNewswire/ -- Golden Biotechnology Corp. (GoldenBiotech, 4132.TWO), a leading Taiwanese biopharmaceutical company, announced that the FDA approved its investigational new drug (IND) application for a Phase II clinical trial of Antroquinonol (Hocena®) on COVID-19 patients in...
Mentice Appoints Thanos Karras as Americas General Manager to Accelerate Group's Growth Strategy
GOTHENBURG, Sweden, July 1, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC) today announced the appointment ofThanos Karras as the company's new General Manager for Americas. Thanos' appointment will play a critical role in supporting Mentice's continual growth strategy and will help accelerate its l...
RhoVac Marketed in International Press
STOCKHOLM, July 1, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") is marketed in the latest edition of the international trade press outlet, MedNous, through a written commentary by CEOAnders Månsson. In order to further attract the attention of potential partners and increase their interest in Rh...
Dr. Cipto Mangunkusumo Hospital Treats Indonesia's First Patient on Varian's Halcyon System
PALO ALTO, California and SINGAPORE, July 1, 2020 /PRNewswire/ -- Dr. Cipto Mangunkusumo Hospital,Jakarta has become the first hospital in Indonesia to treat patients using Varian's Halcyon™ system. The first patient, a 14 year old female, was treated for Hodgkin lymphoma. By 2040, more than 575...
Schindler launches CleanMobility solutions
HONG KONG, July 1, 2020 /PRNewswire/ -- Schindler announces the launch of
CleanMobility
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 323 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 302 media titles]
2024-04-15 17:33AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
[Picked up by 295 media titles]
2024-04-12 15:14Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 275 media titles]
2024-04-15 08:00LEGOLAND® School Challenge 2024 Expands Across Asia and Opens for Registration on April 15th
[Picked up by 275 media titles]
2024-04-11 11:00